MedicarePartD.guide

A non-government resource built from CMS public data

MOMETASONE FUROATE 50 ug Spray, Metered

Coverage in Delaware, DC and Maryland (CMS PDP Region 05).

5 of 10 stand-alone Part D plans in Delaware, DC and Maryland cover this drug on tier 3–4.

4 of 5 plans apply a prior authorization, step therapy or quantity limit.

83 Medicare Advantage plans in DE, DC, MD do cover it

Medicare Advantage plans carry their own formularies, separate from stand-alone Part D. A patient on an MA-PD plan may have coverage even where no PDP lists the drug. DE: 29 plans · DC: 14 plans · MD: 40 plans.

Every plan that covers it

PlanTier30-day preferred90-day mailUnit costEst. 30-day fillRestrictions
SilverScript Choice (PDP)$97.40/mo premium · $615.00 deductible3Preferred Brand18%18%$2.1987$74.7634 units
  • Quantity limit 34 per 30 days
Humana Value Rx Plan (PDP)$4.30/mo premium · $601.00 deductible4Non-Preferred Drug33%—$2.9769$101.2134 units
  • Quantity limit 34 per 30 days
Wellcare Value Script (PDP)$5.60/mo premium · $615.00 deductible4Non-Preferred Drug40%40%$4.7992$163.1734 units
  • Quantity limit 34 per 30 days
AARP Medicare Rx Preferred from UHC (PDP)$94.50/mo premium · $130.00 deductible4Non-Preferred Drug34%—$2.4016—None
Humana Premier Rx Plan (PDP)$108.60/mo premium · $0.00 deductible4Non-Preferred Drug50%50%$2.9618$100.7034 units
  • Quantity limit 34 per 30 days

Cost-sharing is the initial coverage phase at a preferred pharmacy; a percentage is coinsurance of the plan’s negotiated price, and the deductible may apply first. CMS publishes a negotiated price per unit, so the 30-day fill is shown only where the plan’s own quantity limit supplies the quantity.

See coverage in all 39 regions →